Finder makes money from featured partners, but editorial opinions are our own. Advertiser Disclosure
IRIDEX Corporation is a medical devices business based in the US. IRIDEX Corporation shares (IRIX) are listed on the NASDAQ and all prices are listed in US Dollars. IRIDEX Corporation employs 119 staff and has a trailing 12-month revenue of around 0.00.
Our top pick for
Beginners
Our top pick for
Building a portfolio
Our top pick for
Advanced traders
| Latest market close | $2.47 |
|---|---|
| 52-week range | $2.48 - $9.46 |
| 50-day moving average | $3.20 |
| 200-day moving average | $5.34 |
| Wall St. target price | $9.75 |
| PE ratio | N/A |
| Dividend yield | $0 (0%) |
| Earnings per share (TTM) | $-0.36 |
*Signup bonus information updated weekly.
The value of any investment can go up or down depending on news, trends and market conditions. We are not investment advisers, so do your own due diligence to understand the risks before you invest.
The technical analysis gauge below displays real-time ratings for the timeframes you select. This is not a recommendation, however. It represents a technical analysis based on the most popular technical indicators: Moving Averages, Oscillators and Pivots. Finder might not concur and takes no responsibility.
This chart is not advice or a guarantee of success. Rather, it gauges the real-time recommendations of three popular technical indicators: moving averages, oscillators and pivots. Finder is not responsible for how your stock performs.
Historical closes compared with the close of $2.47 from 2022-07-01
| 1 week (2022-06-24) | -9.85% |
|---|---|
| 1 month (2022-06-03) | -14.83% |
| 3 months (2022-03-30) | N/A |
| 6 months (2022-01-03) | -61.53% |
| 1 year (2021-07-02) | -65.31% |
|---|---|
| 2 years (2020-07-02) | 14.35% |
| 3 years (2019-07-03) | 4.13 |
| 5 years (2017-07-03) | 9.61 |
| Revenue TTM | $55.3 million |
|---|---|
| Gross profit TTM | $22.8 million |
| Return on assets TTM | -10.21% |
| Return on equity TTM | -23.87% |
| Profit margin | -10.13% |
| Book value | $1.34 |
| Market capitalisation | $40.8 million |
TTM: trailing 12 months
We're not expecting IRIDEX Corporation to pay a dividend over the next 12 months.
Over the last 12 months, IRIDEX Corporation's shares have ranged in value from as little as $2.48 up to $9.46. A popular way to gauge a stock's volatility is its "beta".
Beta is a measure of a share's volatility in relation to the market. The market (NASDAQ average) beta is 1, while IRIDEX Corporation's is 1.2564. This would suggest that IRIDEX Corporation's shares are more volatile than the average for this exchange and represent, relatively-speaking, a higher risk (but potentially also market-beating returns).
IRIDEX Corporation, an ophthalmic medical technology company, provides therapeutic based laser systems, delivery devices, and consumable instrumentation to treat sight-threatening eye diseases in ophthalmology. It offers laser consoles, such as Cyclo G6 laser system for use in the treatment of glaucoma; IQ 532 and IQ 577 laser photocoagulation systems, which are used for the treatment of diabetic macular edema and other retinal diseases; and OcuLight TX, OcuLight SL, OcuLight SLx, OcuLight GL, and OcuLight GLx laser photocoagulation systems that are used to treat proliferative diabetic retinopathy, macular holes, retinal tears, and detachments. The company also provides delivery devices, including TxCell scanning laser delivery system that allows the physician to perform multi-spot pattern scanning; slit lamp adapter, which allows the physician to utilize a standard slit lamp in diagnosis and treatment procedures; and laser indirect ophthalmoscope for use in procedures to treat peripheral retinal disorders. It offers MicroPulse P3 Probe, which is used with its Cylco G6 laser system to perform MicroPulse transscleral laser therapy; G-Probe, which is used in procedures to treat uncontrolled glaucoma; G-Probe and G-Probe Illuminate, which are used in procedures to treat refractory glaucoma; and EndoProbe family of products for use in vitrectomy procedures. The company serves ophthalmologists, research and teaching hospitals, government installations, surgical centers, hospitals, veterinary practices, and office clinics. It markets its products through direct and independent sales force in the United States, as well as through independent distributors internationally. The company was formerly known as IRIS Medical Instruments, Inc.
Everything we know about the Intchains Group IPO, plus information on how to buy in.
Everything we know about the Biostage IPO, plus information on how to buy in.
Everything we know about the Wang & Lee Group IPO, plus information on how to buy in.
Everything we know about the OptMed IPO, plus information on how to buy in.
Everything we know about the Lichen China IPO, plus information on how to buy in.
Everything we know about the LeeWay Services IPO, plus information on how to buy in.
Everything we know about the Nano Labs IPO, plus information on how to buy in.
Everything we know about the Warrantee IPO, plus information on how to buy in.
Everything we know about the Treasure Global IPO, plus information on how to buy in.
Everything we know about the BIOLIFE4D IPO, plus information on how to buy in.